Please assess the completion status of the following clinical trial:

Trial Title: Cervical Ripening in Postmenopausal Women

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 45-80yrs of age~* Postmenopausal (amenorrhea for greater than 1 year)~* May or may not be using hormone replacement therapy~* Scheduled or to be scheduled for hysteroscopy/resectoscopy procedures~Exclusion Criteria:~* Pregnant~* Known Cancer~* Known hypersensitivity to prostaglandins.~* Those who are breastfeeding

- Gender: FEMALE
- Minimum Age: 45 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Group 1 (Type: ACTIVE_COMPARATOR): Group 1 will received 200ug of misoprostol, to be placed into the posterior vaginal fornix 12 hours and 2 hours before their scheduled surgery (a total of 400ug of misoprostol).
- Group 2 (Type: PLACEBO_COMPARATOR): Group 2 will received placebo (empty gelatin capsule), to be placed into the posterior vaginal fornix 12 hours and 2 hours before their scheduled surgery.

Based on this trial design, predict the completion outcome and termination type (if applicable).